Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement
出版年份 2017 全文链接
标题
Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement
作者
关键词
-
出版物
Frontiers in Neurology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-09-29
DOI
10.3389/fneur.2017.00521
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- From animal models to human disease: a genetic approach for personalized medicine in ALS
- (2016) Vincent Picher-Martel et al. Acta Neuropathologica Communications
- ALS biomarkers for therapy development: State of the field and future directions
- (2015) Michael Benatar et al. MUSCLE & NERVE
- Histological Bulbar Manifestations in the ALS Rat
- (2015) Osama N. Kashlan et al. Neurodegenerative Diseases
- Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
- (2015) Katharine A. Nicholson et al. Neurotherapeutics
- Motor Unit Number Estimation in Neuromuscular Disease
- (2014) Omid Rashidipour et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis
- (2014) T. Lenglet et al. EUROPEAN JOURNAL OF NEUROLOGY
- A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
- (2014) Peter I. Joyce et al. HUMAN MOLECULAR GENETICS
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research
- (2014) Xiaowei W. Su et al. MUSCLE & NERVE
- Preclinical research: Make mouse studies work
- (2014) Steve Perrin NATURE
- A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
- (2014) Michael E. Bozik et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS
- (2013) Theo Hatzipetros et al. BRAIN RESEARCH
- Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
- (2013) Merit E Cudkowicz et al. LANCET NEUROLOGY
- Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
- (2013) LANCET NEUROLOGY
- Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
- (2013) James D. Berry et al. PLoS One
- Electrodiagnosis in Persons With Amyotrophic Lateral Sclerosis
- (2013) Nanette C. Joyce et al. PM&R
- Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS
- (2013) Ettore Beghi et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Electrical impedance myography as a biomarker to assess ALS progression
- (2012) Seward B. Rutkove et al. Amyotrophic Lateral Sclerosis
- Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis
- (2012) K. S. Graffmo et al. HUMAN MOLECULAR GENETICS
- CSF markers in amyotrophic lateral sclerosis
- (2012) Joanna Tarasiuk et al. JOURNAL OF NEURAL TRANSMISSION
- Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
- (2012) Steve Vucic et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial
- (2012) Esther Verstraete et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
- (2012) Elisa Majounie et al. LANCET NEUROLOGY
- A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
- (2012) Luc Dupuis et al. PLoS One
- Emerging drugs for amyotrophic lateral sclerosis
- (2011) Ali Aamer Habib et al. EXPERT OPINION ON EMERGING DRUGS
- Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease
- (2011) Ammar Al-Chalabi et al. HUMAN HEREDITY
- Degenerative Myelopathy in a Bernese Mountain Dog with a Novel SOD1 Missense Mutation
- (2011) F.A. Wininger et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Reproducibility of MUNIX in patients with amyotrophic lateral sclerosis
- (2011) Sanjeev D. Nandedkar et al. MUSCLE & NERVE
- Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: Examining a more efficient trial design
- (2011) R. G. Miller et al. NEUROLOGY
- Guidelines for preclinical animal research in ALS/MND: A consensus meeting
- (2010) Albert C. Ludolph et al. Amyotrophic Lateral Sclerosis
- Effects of gender in amyotrophic lateral sclerosis
- (2010) Pamela A. McCombe et al. Gender Medicine
- Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2010) Swati P Aggarwal et al. LANCET NEUROLOGY
- Lithium carbonate in amyotrophic lateral sclerosis: Lack of efficacy in a dose-finding trial
- (2010) A. Chio et al. NEUROLOGY
- Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability
- (2009) Giuseppe Lauria et al. Amyotrophic Lateral Sclerosis
- A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
- (2009) Robert M. Pascuzzi et al. Amyotrophic Lateral Sclerosis
- Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
- (2009) Vincent Meininger et al. Amyotrophic Lateral Sclerosis
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
- (2009) Petra Kaufmann et al. ANNALS OF NEUROLOGY
- Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis
- (2009) Markus Kraemer et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis
- (2009) M. A. van Es et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Early Excitability Changes in Lumbar Motoneurons of Transgenic SOD1G85R and SOD1G93A-Low Mice
- (2009) Arnaud Pambo-Pambo et al. JOURNAL OF NEUROPHYSIOLOGY
- Electrical impedance myography: Background, current state, and future directions
- (2009) Seward B. Rutkove MUSCLE & NERVE
- Genome-wide association analysis reveals aSOD1mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis
- (2009) Tomoyuki Awano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS
- (2008) Jeffrey Rosenfeld et al. Amyotrophic Lateral Sclerosis
- Protein biomarkers for amyotrophic lateral sclerosis
- (2008) Henrik Ryberg et al. Expert Review of Proteomics
- Neuron-Specific Expression of Mutant Superoxide Dismutase Is Sufficient to Induce Amyotrophic Lateral Sclerosis in Transgenic Mice
- (2008) D. Jaarsma et al. JOURNAL OF NEUROSCIENCE
- Biomarkers in amyotrophic lateral sclerosis
- (2008) Martin R Turner et al. LANCET NEUROLOGY
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
- (2008) E. J. Sorenson et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation